Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5.43M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
12.9M
-
Shares change
-
+10.1M
-
Total reported value, excl. options
-
$591M
-
Value change
-
+$460M
-
Number of buys
-
37
-
Price
-
$45.89
Significant Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q4 2019
39 filings reported holding APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q4 2019.
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.9M shares
.
Largest 10 shareholders include 5AM Venture Management, LLC (2.85M shares), Redmile Group, LLC (2.27M shares), FMR LLC (2.14M shares), JANUS HENDERSON GROUP PLC (1.81M shares), Sectoral Asset Management Inc (1.47M shares), Rock Springs Capital Management LP (724K shares), BlackRock Inc. (344K shares), CITADEL ADVISORS LLC (309K shares), VANGUARD GROUP INC (262K shares), and Artisan Partners Limited Partnership (181K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.